Actionable news
All posts from Actionable news
Actionable news in AIMT: Aimmune Therapeutics Inc,

Nestle gets $145 million stake in food allergy specialist Aimmune

The Nestle logo is pictured on the company headquarters entrance building in Vevey, Switzerland February 18, 2016.

Nestle's (NESN.S) Health Science unit will invest $145 million in U.S. food allergy specialist Aimmune Therapeutics (AIMT.O), the latest move by the Swiss food giant in the health arena, the companies said on Friday.

The investment in new shares will give Nestle a 15 percent stake in Aimmune, and lets the partners work together on developing products to desensitize people with food allergies and protect them from...